Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells

Svetlana Skolekova(Slovak Academy of Sciences), Lucia Kučerová(Cancer Research Institute of the Slovak Academy of Sciences)
Cell Communication and Signaling
January 12, 2016
10.1186/s12964-016-0127-0
Cited by 80

Related Papers

Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation
|BMC Cancer|2016|10
Mirvetuximab Soravtansine Induces Potent Cytotoxicity and Bystander Effect in Cisplatin-Resistant Germ Cell Tumor Cells
|Cells|2025|2
The impact of c-Met inhibition on molecular features and metastatic potential of melanoma cells
|Neoplasma|2024|1